Catalyst Wire Dossier Catalyst Wire Dossier

Hearticellgram-AMI

· Pharmicell Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hearticellgram-AMI, covering 2019-02-15 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration [NA]

See pricing